Health care solutions company AXIM Biotechnologies Inc (OTC:AXIM) plans to use a new patent to formulate a chewing gum with cannabinoids and nicotine that aids tobacco smokers in overcoming their addiction.
The company, an international firm targeting oncological and cannabinoid research, confirmed Wednesday that i received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for the product.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The chewing gum will also be formulated using the company's well-known proprietary chewing gum mechanism.
"AXIM looks to provide a unique and effective solution to the millions of smokers who want to quit smoking," AXIM Biotech CEO John W. Huemoeller II told Benzinga. "With over one billion tobacco smokers worldwide, we have a great opportunity to make a big difference in the $21.8 billion smoking cessation market."
With this new patent issuance, AXIM now holds nine patents, one newly issued allowance and has 13 patents pending. Of these, AXIM is best known for its patent on chewing gum as a delivery mechanism for all cannabinoids, including CBD, THC and the increasingly popular CBG. The company already makes and sells several nutraceutical products including Wellness Gum, Wellness Gum PM, Hole-In-One Gum and Workout Gum.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.